| 000 | 01621 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515110609.0 | ||
| 264 | 0 | _c20081003 | |
| 008 | 200810s 0 0 eng d | ||
| 022 | _a0049-8254 | ||
| 024 | 7 |
_a10.1080/00498250701813222 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKim, H M | |
| 245 | 0 | 0 |
_aIn vitro metabolism of KBH-A40, a novel delta-lactam-based histone deacetylase (HDAC) inhibitor, in human liver microsomes and serum. _h[electronic resource] |
| 260 |
_bXenobiotica; the fate of foreign compounds in biological systems _cMar 2008 |
||
| 300 |
_a281-93 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBiotransformation _xdrug effects |
| 650 | 0 | 4 | _aChromatography, Liquid |
| 650 | 0 | 4 | _aDrug Stability |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xblood |
| 650 | 0 | 4 | _aHistone Deacetylase Inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxamic Acids _xblood |
| 650 | 0 | 4 |
_aLactams _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMass Spectrometry |
| 650 | 0 | 4 |
_aMicrosomes, Liver _xdrug effects |
| 650 | 0 | 4 |
_aPyridones _xblood |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aOh, S J | |
| 700 | 1 | _aPark, S-K | |
| 700 | 1 | _aHan, G | |
| 700 | 1 | _aKim, K | |
| 700 | 1 | _aLee, K S | |
| 700 | 1 | _aKang, J S | |
| 700 | 1 | _aNam, M | |
| 700 | 1 | _aLee, K | |
| 773 | 0 |
_tXenobiotica; the fate of foreign compounds in biological systems _gvol. 38 _gno. 3 _gp. 281-93 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/00498250701813222 _zAvailable from publisher's website |
| 999 |
_c17779765 _d17779765 |
||